Advisors Preferred’s Celgene Corp CELG Stock Holding History

Advisors Preferred’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-436	Closed	-$64K	–	293
2017 Q3	$64K	Buy	436 +325	+293%	+$44.3K	0.04%	140
2017 Q2	$14K	Buy	+111	New	+$13.6K	0.01%	196

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Advisors Preferred's CELG Position: Q4 2017 in Review

Advisors Preferred sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 436 shares — an estimated $64K sold.

Advisors Preferred first reported a position in CELG in Q2 2017 and held it in 2 quarters. The position peaked at $64K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

Advisors Preferred reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
Advisors Preferred sold 436 Celgene Corp shares in Q4 2017, an estimated $64K.
Advisors Preferred first reported a position in Celgene Corp in Q2 2017 and held it in 2 quarters.
Advisors Preferred's Celgene Corp position peaked at $64K in Q3 2017.
1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Advisors Preferred's 13F filing for Q4 2017, filed 12 Feb 2018.